Charlottesville, VA (9 September 2009): Biovista Inc. announced today that it will present at the CHI  Drug Repositioning Summit in Boston, MA, Oct. 13-14, 2009. The presentation will highlight the efficiencies of repositioning as a development strategy, and introduce Biovista’s proprietary platform for repositioning and adverse event profiling. BVA-101, 201 and 601 will be presented as case studies of repositioning.

Part of CHI’s Pipeline Success Summit, the Drug Repositioning Summit will focus on latest technologies, successful case studies and neglected/uncommon diseases  that are of interest to drug repositioning professionals.